Product Description
Treatment that is accepted by medical experts as a proper treatment for a certain type of disease and that is widely used by healthcare professionals. Also called best practice, standard medical care, and standard therapy.
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Nondrug
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
03/12/2026 |
News Article |
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update |
|
03/12/2026 |
News Article |
Heru Showcases PretestPro™ for the Heru VR-Powered Diagnostic Headset at Vision Expo |
|
03/12/2026 |
News Article |
Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal® |
|
03/12/2026 |
News Article |
Combat Medical Raises £2.6 Million Series A to Advance Treatment of BCG Unresponsive Bladder Cancer |